What are the recommended asthma maintenance therapy and acute exacerbation management protocols for the NAC OSCE Canada exam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Asthma Treatment and Exacerbation Management - NAC OSCE Canada

CHRONIC ASTHMA MAINTENANCE THERAPY

For chronic asthma, use a stepwise approach based on severity, with inhaled corticosteroids (ICS) as the foundation of treatment starting at Step 2. 1

Step 1: Intermittent Asthma

  • Preferred: Short-acting beta-agonist (SABA) as needed only
  • Examples: Salbutamol/albuterol 2 puffs PRN

Step 2: Mild Persistent Asthma

  • Preferred: Low-dose ICS daily
  • Alternatives: Leukotriene receptor antagonist (montelukast), cromolyn, or nedocromil 1
  • Example: Fluticasone 100-250 mcg daily

Step 3: Moderate Persistent Asthma

  • Preferred: Low-to-medium dose ICS + long-acting beta-agonist (LABA)
  • Alternative: Medium-dose ICS alone, OR low-to-medium dose ICS + leukotriene modifier 1, 2
  • Example: Fluticasone/salmeterol (Advair) 250/50 mcg twice daily

Step 4: Moderate-Severe Persistent Asthma

  • Preferred: Medium-dose ICS + LABA
  • Alternative: Medium-dose ICS + leukotriene modifier 1

Step 5: Severe Persistent Asthma

  • Preferred: High-dose ICS + LABA
  • Consider: Omalizumab for allergic asthma 1

Step 6: Very Severe Persistent Asthma

  • Preferred: High-dose ICS + LABA + oral corticosteroids
  • Consider: Omalizumab for allergic asthma 1

Key Point: Never use SABA alone for persistent asthma - always add ICS to reduce exacerbation risk and mortality 3, 4.


ACUTE ASTHMA EXACERBATION MANAGEMENT

For acute exacerbations, immediately give oxygen, repetitive SABA, and systemic corticosteroids - these three medications form the cornerstone of emergency treatment. 5, 6, 7

Initial Assessment - Severity Classification

Mild Exacerbation:

  • Dyspnea only with activity
  • Peak flow ≥70% predicted
  • Speaks in sentences

Moderate Exacerbation:

  • Dyspnea interferes with activity
  • Peak flow 40-69% predicted
  • Speaks in phrases
  • Respiratory rate increased

Severe Exacerbation:

  • Dyspnea at rest
  • Peak flow <40% predicted
  • Speaks in words only
  • Respiratory rate >30/min
  • Heart rate >120 bpm
  • Accessory muscle use

Life-Threatening Features:

  • Silent chest, cyanosis, poor respiratory effort
  • Altered consciousness, exhaustion
  • Oxygen saturation <92%
  • Peak flow <33% predicted 5, 8, 9

Emergency Treatment Protocol

IMMEDIATE ACTIONS (First Hour):

  1. Oxygen: Start immediately to maintain SpO2 ≥90% (≥95% in children) 5, 6

  2. SABA - First Line:

    • Adults: Salbutamol 2.5-5 mg nebulized OR 4-8 puffs MDI with spacer
    • Children: Salbutamol 2.5 mg (age <2) or 5 mg (age ≥2) nebulized
    • Repeat every 20 minutes for 3 doses 5, 6
    • Can give continuously at 10-15 mg/hour for severe cases 5
  3. Systemic Corticosteroids - Give Early:

    • Adults: Prednisone 40-60 mg PO OR hydrocortisone 200 mg IV
    • Children: Prednisone 1-2 mg/kg (max 60 mg) PO
    • Give within first hour - no benefit to IV over oral if patient can swallow 5, 8, 6
  4. Ipratropium Bromide - Add for Severe/Life-Threatening:

    • Adults: 0.5 mg nebulized with SABA every 20 minutes for 3 doses
    • Children: 0.25-0.5 mg nebulized
    • Can mix with SABA in same nebulizer 5, 6
    • Important: Only beneficial in first 3 hours; no benefit once hospitalized 5

Reassess After 1 Hour

Good Response (Peak flow >70%, no distress):

  • Continue SABA every 3-4 hours
  • Continue oral corticosteroids
  • Consider discharge if sustained improvement

Incomplete Response (Peak flow 40-69%, persistent symptoms):

  • Continue SABA every 1-2 hours
  • Continue oxygen and corticosteroids
  • Consider admission

Poor Response (Peak flow <40%, severe symptoms persist):

  • Admit to hospital
  • Continue frequent SABA
  • Consider IV magnesium sulfate 2 grams over 20 minutes 10
  • Consider IV salbutamol or subcutaneous epinephrine 0.3-0.5 mg for life-threatening cases 5

Medications NOT Recommended in First 4 Hours

  • Aminophylline/theophylline - no benefit, increases side effects 6
  • Antibiotics - unless clear bacterial infection 8
  • Sedatives - absolutely contraindicated 8

Criteria for ICU Admission

  • Worsening hypoxia despite 60% oxygen
  • Hypercapnia (PaCO2 >45 mmHg)
  • Exhaustion, confusion, drowsiness
  • Respiratory arrest 8

DISCHARGE PLANNING

Discharge when:

  • Peak flow >60-80% predicted AND sustained for 1 hour
  • Minimal symptoms at rest
  • No nocturnal symptoms
  • Oxygen saturation >90% on room air 8, 10

Discharge Medications:

  1. Prednisone 40-60 mg daily for 5-10 days (no taper needed) 5, 6
  2. Start or increase ICS - all patients need this 6
  3. SABA for rescue - continue as needed
  4. Written asthma action plan - mandatory 9, 4

Follow-up: Within 2-7 days with primary care or respirologist 6, 10


Common Pitfalls to Avoid

  • Don't use SABA alone for maintenance - always add ICS to prevent death 3, 4
  • Don't delay corticosteroids - give in first hour of exacerbation 5, 6
  • Don't use aminophylline in acute setting - no benefit, more side effects 6
  • Don't forget ipratropium for severe exacerbations - reduces hospitalizations 5
  • Don't discharge without ICS - prevents future exacerbations 6
  • Don't use IV corticosteroids unless patient vomiting - oral works equally well 5

References

Research

Update on Asthma Management Guidelines.

Missouri medicine, 2024

Research

Treatment for acute asthma in the Emergency Department: practical aspects.

European review for medical and pharmacological sciences, 2010

Research

Acute Asthma Exacerbations: Management Strategies.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.